Lexeo Therapeutics (LXEO) Research & Development (2022 - 2026)
Lexeo Therapeutics' Research & Development was $19.03 million in Q2 2026, up 29.3% from $14.72 million a year earlier and up 21.2% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Research & Development (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Lexeo Therapeutics' Research & Development was $66.64 million through Jun 30, 2026, down 9.6% year-over-year; for FY2025, it was $63.8 million, down 13.9% from FY2024.
- Research & Development shows a three-year compound annual growth rate of 9.1% (FY2022 to FY2025).
- In earlier years, Research & Development was $74.09 million in FY2024 (+39.5%), $53.13 million in FY2023 (+8.1%) and $49.16 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Research & Development since Q3 2024.
- Compared with a year earlier, Research & Development was higher in four of the last eight quarters, with growth averaging 16.7%.
- The best year-over-year quarter for Research & Development over five years was Q4 2024 (growth of 123.7%); the worst was Q3 2025 (a decline of 33.0%).
- Per Business Quant data, LXEO's Research & Development in the three quarters before Q2 2026 was $15.7 million (Q1 2026), $16.21 million (Q4 2025) and $15.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Lexeo Therapeutics | 248.75 Mn | -411.66 Mn | - | 19.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.03 Mn |
| Mar 31, 2026 | 15.70 Mn |
| Dec 31, 2025 | 16.21 Mn |
| Sep 30, 2025 | 15.70 Mn |
| Jun 30, 2025 | 14.72 Mn |
| Mar 31, 2025 | 17.17 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Sep 30, 2024 | 23.42 Mn |
| Jun 30, 2024 | 16.56 Mn |
| Mar 31, 2024 | 15.74 Mn |
| Dec 31, 2023 | 8.21 Mn |
| Sep 30, 2023 | 17.25 Mn |
| Jun 30, 2023 | 11.24 Mn |
| Mar 31, 2023 | 16.44 Mn |
| Dec 31, 2022 | 11.39 Mn |
| Sep 30, 2022 | 15.36 Mn |
API Access
Lexeo Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();